Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q2 FY2021 Earnings Presentation
12 slides from Phibro Animal Health's earnings presentation, Feb 4, 2021
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call Financial Results February 4, 2021 Second Quarter - ended December 31, 2020 U.S. toll-free +1-833-968-1955 Fiscal Year 2021 International toll +1-647-689-6656 Conference ID: 3288725
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward- looking statemen
Slide 3: Key Themes
Key Themes Quarter Ended December 31, 2020 Projecting Continued Solid financial Stabilization in another strong investment in the results our industry quarter future Excited Encouraged Expecting Planning about our by signs the solid continued solid industry is financial investment second stabilizing
Slide 4: Pet Business Update
Pet Business Update Continuing to identify opportunities in the multi-billion dollar pet business In Although COVID-19 has limited access to clinics, sales doubled in the last six months versus prior Line six months, and we are confident we will continue to penetrate the market Estimated Addre
Slide 5: Performance Summary
Financial Performance Summary Second Quarter versus Prior Year 4% 8% 10% 0% 0% 0% Adjusted Adjusted Net Net Diluted Adjusted Net Diluted Sales Income EPS EBITDA Income EPS Financial performance is shown vs. the same quarter of the prior year. Adjusted results adjust GAAP results for one-offs, acquis
Slide 6: Financial Performance
Financial Performance Second Quarter versus Prior Year $ in millions, except per share data YOY Net Sales – 4% decrease driven by declines in Animal Health and Mineral Q2 %∆ Nutrition, partially offset by increase in Performance Products Net Sales $ 206.1 (4)% Net Income & Diluted EPS – 8% and N
Slide 7: Financial Performance – Animal Health
Financial Performance – Animal Health Second Quarter versus Prior Year $ in millions YOY Net Sales Q2 %∆ MFAs and other Net Sales $ 136.2 (5%) - Lower international demand offset by favorable domestic customer order patterns MFAs & other 81.6 (11%) Nutritional specialties Nutritional Specialti
Slide 8: Financial Performance – Other Segments
Financial Performance – Other Segments Second Quarter versus Prior Year $ in millions Mineral Nutrition YOY - Sales decline driven by lower average selling prices Q2 %∆ correlated with the movement of the underlying raw material costs Mineral Nutrition - Adjusted EBITDA driven by increased gross p
Slide 9: Key Capitalization Metrics
Key Capitalization Metrics Second Quarter Highlights Cash Flow $19 million of cash provided before financing 3.6x gross leverage ratio; $387 million total debt / $107 Leverage million trailing 12-month Adjusted EBITDA Liquidity $165 million; $96 million of cash and short-term investments + $69 milli
Slide 10: Financial Guidance
Financial Guidance Third Quarter - ending March 31, 2021 We expect third quarter financial results as follows: Expected Third Quarter Net Sales $205 - 208 million Net Income $11 - 12 million Diluted EPS $0.27 - $0.30 Adjusted EBITDA $27 - 29 million Adjusted Net Income $12.0 - 13.5 million Adjuste
Slide 11: Q&A
Q&A 11 February 4, 2021 Webcast and Conference Call
Slide 12: © 2021 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2021 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q2 FY2021 Earnings Presentation on 6ix